<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04978831</url>
  </required_header>
  <id_info>
    <org_study_id>10368355</org_study_id>
    <nct_id>NCT04978831</nct_id>
  </id_info>
  <brief_title>The Effect of Use of Breathing Exercise Device and Reading Aloud on Vital Signs</brief_title>
  <official_title>The Effect of Use of Breathing Exercise Device and Reading Aloud on Vital Signs, Fatigue and Pulmonary Function Parameters in Patients With COPD Who Followed Up by Wearable Technology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inonu University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inonu University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose of the research; To determine the effects of wearable technology follow-up, breathing&#xD;
      exercises with a breathing exercise device and reading aloud on vital signs, fatigue and&#xD;
      respiratory function parameters in individuals with COPD. This research will be conducted&#xD;
      using a randomized controlled trial model. &quot;Personal Description Form&quot;, &quot;COPD and Asthma&#xD;
      Fatigue Scale&quot;, Visual Analog Scale and pulmonary function tests will be used in data&#xD;
      collection.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2020</start_date>
  <completion_date type="Anticipated">November 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pulmonary Function Parameters</measure>
    <time_frame>2 month</time_frame>
    <description>Change in FEV1/FVC ratio will be evaluated with pulmonary function test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fatigue</measure>
    <time_frame>2 month</time_frame>
    <description>The COPD and Asthma Fatigue Scale was developed by Revicki et al in 2010 to reveal the effect of COPD and Asthma on fatigue. The items of the questions in the scale, which consists of 12 questions in total, are graded with a 5-point Likert type as &quot;never&quot;, &quot;rarely&quot;, &quot;sometimes&quot;, &quot;often&quot;, &quot;very often&quot;. A total of 12 to 60 points is obtained from the scale. A single score is obtained from the scale for the state of fatigue, and there is no evaluation of the sub-dimensions. An increase in this score indicates that the person's fatigue level is high.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">96</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <condition>Breath Shortness</condition>
  <arm_group>
    <arm_group_label>Respiratory exercise device group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Reading aloud group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PEP Device</intervention_name>
    <description>The breathing exercise device is a device that simulates pursed lip breathing by creating positive expiratory pressure (PEP). Before starting to use the device, it will be explained that they need to put the mouthpiece on the device and put the nose clip on their nose, and the participants will be shown how it is done. The device will be used at 5 cmH2O pressure. A single exercise session consists of 3 exercise cycles, and a single exercise cycle will consist of 15 inhale-exhale activities. The blood pressure, heart rate and saturation values of the participants will be monitored with the smart watch.</description>
    <arm_group_label>Respiratory exercise device group</arm_group_label>
    <other_name>Smart Watch</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Reading Aloud</intervention_name>
    <description>Participants will be asked to read the given books aloud for 15 minutes, three times a day, sitting upright on a chair or armchair. Participants will read aloud as in the instructions given to them. The blood pressure, heart rate and saturation values of the participants will be monitored with the smart watch.</description>
    <arm_group_label>Reading aloud group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Having been diagnosed with COPD for at least 6 months or before&#xD;
&#xD;
          -  Not having a respiratory system defect caused by diseases other than COPD&#xD;
&#xD;
          -  Not in the GOLD-4 COPD stage&#xD;
&#xD;
          -  Being able to read and write Turkish&#xD;
&#xD;
          -  Have no problems communicating or speaking&#xD;
&#xD;
          -  Being able to use basic information technologies&#xD;
&#xD;
          -  Using a smartphone&#xD;
&#xD;
          -  Having an active internet connection&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Having non-COPD pulmonary problems and diagnosed cardiovascular disease&#xD;
&#xD;
          -  Not volunteering to participate in the study&#xD;
&#xD;
          -  Having a psychiatric disorder such as schizophrenia or dementia that disrupts the&#xD;
             thought process&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gürkan Özden, MSc</last_name>
    <phone>+905057156265</phone>
    <email>gurkan.ozden@inonu.edu.tr</email>
  </overall_contact>
  <location>
    <facility>
      <name>İnönü University</name>
      <address>
        <city>Malatya</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gürkan Özden, MSc</last_name>
      <phone>+905057156265</phone>
      <email>gurkan.ozden@inonu.edu.tr</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>McNamara RJ, Epsley C, Coren E, McKeough ZJ. Singing for adults with chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev. 2017 Dec 19;12:CD012296. doi: 10.1002/14651858.CD012296.pub2. Review.</citation>
    <PMID>29253921</PMID>
  </reference>
  <reference>
    <citation>Wang YT, Green JR, Nip IS, Kent RD, Kent JF. Breath group analysis for reading and spontaneous speech in healthy adults. Folia Phoniatr Logop. 2010;62(6):297-302. doi: 10.1159/000316976. Epub 2010 Jun 28.</citation>
    <PMID>20588052</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 17, 2021</study_first_submitted>
  <study_first_submitted_qc>July 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 27, 2021</study_first_posted>
  <last_update_submitted>July 17, 2021</last_update_submitted>
  <last_update_submitted_qc>July 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inonu University</investigator_affiliation>
    <investigator_full_name>Gürkan ÖZDEN</investigator_full_name>
    <investigator_title>Research Assistant</investigator_title>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>Fatigue</keyword>
  <keyword>Breath exercise</keyword>
  <keyword>Reading aloud</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Dyspnea</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

